Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2026)
Aquestive Therapeutics (AQST) recorded quarterly Times Interest Earned of -$1.45 in Q1 2026, up 86.05% quarter-over-quarter from -$10.38 in Q4 2025, and up 79.2% on a YoY basis from -$0.81 in Q1 2025.
Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Times Interest Earned history runs 10 years deep, the most recent figure standing at -$1.45 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 79.2% year-over-year to -$1.45; the TTM figure through Mar 2026 stood at -$4.97 (down 34.26% YoY), while the FY2025 annual figure was -$6.39, down 130.94% from the prior year.
- Times Interest Earned was -$1.45 for Q1 2026 at Aquestive Therapeutics, up from -$10.38 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $0.02 in Q2 2024 to a low of -$10.38 in Q4 2025.
- Historically, Times Interest Earned has averaged -$4.33 across 5 years, with a median of -$4.09 in 2025.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned soared 100.65% in 2024, then tumbled 20754.23% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$6.49 in 2022, then soared by 73.5% to -$1.72 in 2023, then sank by 183.98% to -$4.89 in 2024, then plunged by 112.46% to -$10.38 in 2025, then surged by 86.05% to -$1.45 in 2026.
- The last three Times Interest Earned figures came in at -$1.45 (Q1 2026), -$10.38 (Q4 2025), and -$4.13 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Aquestive Therapeutics | 488.60 Mn | 377.87 Mn | 10.98 Mn | -1.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.45 |
| Dec 31, 2025 | -10.38 |
| Sep 30, 2025 | -4.13 |
| Jun 30, 2025 | -4.09 |
| Mar 31, 2025 | -6.96 |
| Dec 31, 2024 | -4.89 |
| Sep 30, 2024 | -2.98 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | -3.22 |
| Dec 31, 2023 | -1.72 |
| Sep 30, 2023 | -1.89 |
| Jun 30, 2023 | -3.07 |
| Mar 31, 2023 | -3.21 |
| Dec 31, 2022 | -6.49 |
| Sep 30, 2022 | -5.37 |
| Jun 30, 2022 | -7.81 |
| Mar 31, 2022 | -6.02 |
| Dec 31, 2021 | -6.69 |
| Sep 30, 2021 | -2.86 |
| Jun 30, 2021 | -2.36 |